Related by context. All words. (Click for frequent words.) 59 duration 58 durations 55 Main Outcome Measure 53 Main Outcome Measures 50 Length 49 Durations 49 untreated psychosis 48 Score IPSS 48 Score DAS# 47 Elapsed 47 Pain Intensity 47 Index CDAI 47 Outcome Measures 46 Prolongation 46 #:# mediaQueryString http:/static.washingtonposFilmworkers 46 ‰ ¥ 46 #:# mediaQueryString http:/static.washingtonpostZanatta 46 Loss Severity 46 Minimum 45 Left Ventricular Ejection Fraction 45 Sleep Disturbance 45 intravaginal ejaculatory latency 45 Lower Limb 45 brightness backlight 45 Score DAS 45 Visual Analogue Scale VAS 45 Erectile Function IIEF 45 International Prostate Symptom 45 Years Duration Corporate 44 Approximate 44 Crohn Disease Activity 44 interquartile range 44 Callable 44 Clinical Outcome 44 plasma cortisol 44 Predict Prostate Cancer 44 postintervention 44 Nocturia 44 HAQ DI 44 Guaranteed Withdrawal 44 Chronic Illness Therapy 44 Frequency 44 Physiologic 44 posttreatment 44 Strength Rating 44 Sexual Satisfaction 44 IELT 44 Tracking Error 44 ADAS cog 44 Secondary endpoints include 43 Scale EDSS score 43 NIH CPSI 43 dosing interval 43 expiratory flow 43 Timeframe 43 Top Quartile 43 Our PMVS 43 Modifiable 43 Severity Index 43 Competitive Salary 43 Sharpe Ratio 43 Constant Maturity 43 postvaccination 43 QRS duration 43 walk distance 6MWD 43 dosed intravenously 43 6MW distance 43 Scale EDSS 43 Platelet Aggregation 43 Maximum 43 % Confidence Interval 42 repeat paracentesis 42 Maximal 42 crossclamp 42 Kaplan Meier estimates 42 Somnolence 42 CIBIC + 42 CDAI 42 Actively Managed 42 Conversion Ratio 42 Inhaled Nitric Oxide 42 Symptom Scale 42 msec 42 Various Types 42 Seattle Angina Questionnaire 42 QTc intervals 42 Secondary endpoints included 42 Aggressive Growth Portfolio 42 WAIS III 42 Frequency Response 42 Persistent Sleep 42 androgen suppression 42 6MWD 42 Settlement Date shall 42 lymphocyte subsets 42 Inventory BPI 42 Antidepressant Treatment 42 Prostate Cancer Risk 42 SSAO 42 Tasigna prolongs 42 Technically Acceptable 42 Aspect Ratio 42 Negotiable 42 salivary cortisol 42 ROP Term 42 Assessment Questionnaire 42 IQR 42 postdose 42 Return IRR x Amortized 42 interquartile range IQR 42 Adjustable Rate 42 rFSH 42 Reduces Breast Cancer 42 concentration Cmax 42 Appears Safe 42 QTc 42 ≥ Grade 42 DAS# remission 41 Repricing 41 ± SEM 41 #:# mediaQueryString 41 Variables 41 urinary sodium excretion 41 CDAI score 41 STRIDE PD 41 Attenuation 41 progression TTP 41 annualized relapse 41 Systolic Blood Pressure 41 ADAS Cog 41 Summary Table 41 Breast Density 41 Kidney Function 41 Gentle Path compound 41 SpO 2 41 Equivalent 41 moderately emetogenic 41 Calories Burned 41 Blood Clot Risk 41 Evaluative 41 Variable Interest Rate 41 #/#.# #/#.# [001] 41 Coefficients 41 ps rms 41 Floating Rate Debt 41 Yield Curve 41 Smoothed 41 antiretroviral naive 41 Sleep Disturbances 41 PMVS 41 Diamyd Medical Diamyd 41 Measurement Period 41 apnea hypopnea 41 maturity WAM 41 Extended 41 Statistically Significant 41 Potency 41 = #.#f 41 Intervals 41 PG-#. 41 activated partial thromboplastin 41 Preferable 41 Determination Date 41 pulmonary exacerbations 41 ADCS CGIC 41 AUD USD -#.# 41 Basis Points 41 mean ± SEM 41 Improves Outcomes 41 Likert pain 41 Vessel Vessel Type 41 Venous thromboembolism 41 Lasts 41 Chart Presentation 41 Depressive Symptoms 41 Fixed Remuneration 41 Funds Announce 41 Kaplan Meier 41 GETTING PERSONAL CANADA 41 Difficulty Easy 41 Negligible 41 -#/# [003] 41 Lactate 41 Minimum Qualifications 41 QT intervals 41 serum aminotransferase levels 41 QTcF 41 lasts 41 Measurement Uncertainty 41 Watchful Waiting 41 IRLS score 41 covariance 41 MIL HDBK #F 41 Fixed Rate Mortgage 40 GnRH agonist 40 MBS AFTERNOON 40 Oswestry Disability Index 40 EORTC QLQ C# 40 No Lapse Guarantee 40 Heel Pain 40 Acting Injection 40 len = 40 Claudication 40 demonstrated clinically meaningful 40 PLMs 40 sd = 40 exp MORE 40 -India Kanishka bombing 40 Debt Obligation 40 Renal Function 40 ventricular repolarization 40 mortality morbidity 40 ≤ 40 Personality Traits 40 inspiratory 40 Lengthened 40 DOQ 40 Qmax 40 Gestation 40 Virologic Response 40 Correlation 40 ± SD 40 â ‰ ¥ 40 Yield 40 Improving Efficiency 40 Dementia Risk 40 NIHSS score 40 esophageal acid 40 EDSS scores 40 mg/m2/day 40 -* Newtek 40 Discount Rate 40 Yields Decline 40 Req 40 Dosage 40 Varies 40 Kaplan Meier estimate 40 Hue Saturation 40 Interpolation 40 Apgar scores 40 Brief Pain 40 Dividend Rate 40 Double Blind Randomized 40 nasal aerosol 40 Magnetic Stimulation 40 Shutter speeds 40 Remains Unchanged 40 Exercise Induced Asthma 40 RNA copies mL 40 Patients Receiving 40 secondary efficacy endpoint 40 Minimums 40 Creditworthiness 40 Genre Comedy 40 -Norvic 40 Variable 40 Δ 40 severe neutropenia 40 Secondary Endpoints 40 Long Term Outcomes 40 ug kg 40 QRS width 40 Severity 40 spirometric 40 Lupus Drug 40 Maturities 40 Hybrid ARMs 40 neurologic dysfunction 40 peak VO2 40 creatinine clearance CrCl 40 linear regression models 40 varying durations 40 Equiv 40 Disclosure Requirement 40 pa pro rata 40 Inductance 40 ALT elevation 40 Bitrate 40 polysomnography PSG 40 divalproex sodium 40 cm sec 40 Menopause Symptoms 40 www.frequencyelectronics.com 40 6MWT 40 EXD 40 Duration Gap 40 mg q8h 40 oral prednisolone 40 WOMAC pain 40 Workweek 40 FFNS 40 Visual Acuity 40 Credit Card Interest Rates 40 Color Temperature 40 DAS# CRP 40 Cyclic 39 Not Disclosed 39 symptomatic intracranial hemorrhage 39 Conformational 39 refigured automatically every 39 foveal thickness 39 Mth 39 DWORD 39 Shortens 39 Yld 39 LIBOR indexed 39 Default Rate 39 urinary N telopeptide 39 #,#,#,# [006] 39 ω 39 Month Avg 39 Calorimeter 39 Easting Northing 39 VQT 39 YMRS 39 ICICI Pru MF 39 Pearson correlation coefficient 39 -Powerstream 39 Alerian MLP Infrastructure 39 photoperiod 39 Laddered 39 Effective Treatments 39 Secondary endpoints 39 hh mm ss 39 digit DMM 39 AUC0 39 Occupancy Rate 39 preintervention 39 Free Survival PFS 39 Non Inferiority 39 IU ml 39 Interest Drawdown Date 39 Vectical TM Ointment 39 pulse width 39 Androgen Deprivation 39 Prognostic Factors 39 Deferral 39 Discontinuous 39 Sched 39 Flesch Reading 39 Financing Costs 39 Telomere 39 Tolerances 39 Mycophenolate mofetil 39 Hourly Rate 39 Irvine Sensors Receives 39 Inclination 39 CUSIP Redemption Date 39 Abbreviated 39 orthostatic 39 Allowable 39 CYT# QbG# 39 Fundamental Outlook 39 Perimenopause 39 central corneal thickness 39 Viral Load 39 Figure S4 39 Exercise Expiry 39 Inflammatory Response 39 Jobless Claims Climb 39 genotypic resistance 39 Load Structure 39 Radiation Dose 39 Tenure Track Faculty 39 Newsflashes 39 Circadian Rhythm 39 ancrod 39 Particle Size 39 Pre Cancerous 39 ml kg 39 Annual Reset 39 Unfractionated Heparin 39 EDSS score 39 Orthostatic Hypotension 39 Tmax 39 Boosts Survival 39 CIMZIA R 39 Indeterminate 39 mso font pitch 39 Flexible Lifetime 39 #mg q8h 39 Low Duration 39 variable 39 WIDTH 39 varies depending 39 gain amplifiers VGAs 39 confidence intervals CIs 39 NATRECOR ® 39 Coronary Arteries 39 Breast Tissue 39 convexity 39 Period 39 pegylated IFN 39 .cagy veteran 39 Rates Remain 39 Lesion 39 C.2 39 Glycemic Control 39 Content Outline 39 Expiration Dates 39 IBDQ 39 swaps 2s #.#bps 39 Localized Prostate Cancer 39 urinary albumin excretion 39 Tarmac Delays 39 estimated glomerular filtration 39 Insulin PH# 39 Chemotherapy Improves 39 echocardiographic parameters 39 Dilatation 39 Flexible 39 Neonatal Mortality 39 #.# Years Duration 39 Further Validates 39 PSQI 39 desaturation 39 Secondment 39 CI# [002] 39 inhaled budesonide 39 dipyridamole plus 39 Quarterly Interval Plan 39 fraction LVEF 39 Illiquidity Risk 39 categorical variables 39 Strongly Linked 39 Mantel Haenszel 39 serum phosphate 39 Leverage Ratios 39 Maturity 39 Predictive Value 39 Predict Risk 39 intraclass correlation coefficient 38 Copano Energy Announces 38 radiographic progression 38 lactate dehydrogenase LDH 38 Exp. 38 KEMET Announces 38 - -Mike Lopuchovsky 38 Genetic Defect 38 + 2EV 38 Intermediate Term 38 # endif 38 -Queen Elizabeth Stakes Eng 38 Hip Fracture Risk 38 Acquisi 38 daytime somnolence 38 timebase 38 Vitamin D Supplementation 38 Interest Rates Remain 38 Hemoglobin Levels 38 Index Plus EMBI 38 Currency Basket 38 #.#EV 38 INVEGA ® 38 GI motility 38 Alanine 38 RockTenn Announces 38 Shortened 38 wrist actigraphy 38 Lengthen 38 peak plasma concentrations 38 MALVERN LINK 38 Pac Lf 38 Lending Rates 38 Selectivity 38 Expiration 38 Vrms 38 Prolonged Exposure 38 Evergreen Closed End 38 x ULN 38 Reverse Repos 38 overt nephropathy 38 alteplase 38 First BanCorp Announces 38 Liquidity Adjustment Facility 38 Unsecured Debt 38 - -Michael Kurtanjek 38 Skin sterol 38 adenotonsillectomy 38 Avg. 38 SCr 38 oxyhemoglobin 38 intervals 38 Repricing Gap 38 Medication Compliance 38 PG. 38 Genetic Variants 38 plasma concentration Cmax 38 hue saturation 38 QTc interval prolongation 38 CPAP adherence 38 Secondary efficacy endpoints 38 UST Reference 38 antibody titer 38 Treasury Yield Curve 38 #-#-# Maturity 38 Salary Range 38 renal cysts 38 #bar [001] 38 Charter Equivalent 38 evaluable subjects 38 dipyridamole 38 Selectable 38 + #.#dB 38 QALE 38 Can Predict 38 anogenital distance 38 Male Pattern Baldness 38 Recency 38 MZF 38 Logistic Regression 38 Required Qualifications 38 Collateralised Borrowing 38 correlation coefficients 38 Lease Obligations 38 Aliasing 38 CK # plasma 38 Differential Diagnosis 38 gastric acid secretion 38 Cardiorespiratory fitness 38 Iterations 38 Years Effective Duration 38 ug dose 38 Euro Trades Near 38 Hormone Levels 38 Comparators 38 Preferred Qualifications 38 nausea somnolence 38 Liquidity Position 38 Partial Nephrectomy 38 BPRS PSS 38 Evaluable 38 Linear Programming 38 Symptom severity 38 Variable Compensation 38 symptom exacerbation 38 Elongation 38 relapsed MM 38 Amortized Cost 38 Minimized 38 Longer Term 38 Reverses Gains 38 NOT NULL 38 Inflation Protected 38 bronchodilation 38 Composite Query 38 Significantly Reduced 38 cyclicity 38 cecal intubation 38 Shutter Speed 38 Minyan Mailbag 38 Anticancer Activity 38 -PACCAR PCAR 38 disease progression TTP 38 Osteoarthritis Pain 38 Continuing Monthly Distributions 38 OFZ curve 38 Between Failure MTBF 38 Breast Cancer Recurrence 38 follicular phase 38 citalopram hydrobromide 38 Currency Translation 38 Spreads Narrow 38 Calibrated 38 fever chills muscle aches 38 periprocedural 38 FTE Avg 38 Fixed Rate Mortgages 38 reactogenicity 38 Reduces Pain 38 Ionospheric 38 Percentile 38 HBeAg seroconversion 38 -megabases 38 Font Size 38 #.#-#.# [011] 38 AST# 38 Differential Pressure 38 FACIT 38 pegylated interferon alfa 2b 38 Determinant 38 Volumetric 38 Prognostic 38 Gene Mutation 38 racemic albuterol 38 prothrombin 38 Dispersion 38 Observable 38 ICVC 38 Uterine 38 Antenna Modeling 38 Provides Unprecedented 38 Segregated Funds 38 Actively Managed ETFs 38 Parameter 38 carboplatin AUC 6 38 brachial artery flow 38 Life Expectancy 38 MΩ 38 Refining Margin 38 ETF TBT 38 Piston Pump 38 linewidth 38 pretransplant 38 LATUDA 38 Power Dissipation 38 PegIFN RBV 38 Potentiometer 38 CLV DAC 1C 38 WebTech Wireless Announces 38 Natural Catastrophe Stress 38 Yr Yield 38 min max 38 HAM D# 38 acromegalic patients 38 Number Departs Arrives 37 #K #K [002] 37 Fibromyalgia Pain 37 Grade Thickness 37 prospectively stratified 37 Calorimetry 37 Lengthening 37 Expiry 37 Acne Scars 37 CK MB 37 CREL CDO 37 CSBM 37 requi MORE 37 PDL BioPharma Announces 37 serum magnesium 37 nasal symptom 37 interobserver 37 Installers Drug 37 HOLE NO 37 PLMS 37 Guaranteed Minimum Withdrawal 37 Sleep Patterns 37 Individualized 37 Indefinite Delivery 37 Microstructure 37 QT syndrome 37 SINAD 37 #.#x #.#x #.#x #.#x [001] 37 DLTs 37 Dramatically Improves 37 Price Per Ounce 37 Terminal Illness 37 Pos Driver Make 37 Disclosure Controls 37 creatine kinase MB 37 Maternity Cover 37 extubation 37 autocorrelation 37 Currency Swaps 37 CI -#.# 37 TURBT 37 covariance ANCOVA 37 5s #.#bps #s 37 Rates Rise 37 Brain Metastases 37 Mental Status 37 Funded Debt 37 Multiplies 37 mL kg 37 Fixed Rate 37 Evaluation Process 37 -Baharin 37 decibel dB 37 carboplatin AUC 37 rearfoot 37 sunrise sunset moonrise 37 Predict Breast Cancer 37 Proves Successful 37 Fund NYSE CSQ 37 Switchable 37 #us [001] 37 Bone Marrow Cells 37 Medicure Announces 37 Anworth Announces 37 Neurophysiological 37 #,#-# [012] 37 Predefined 37 ropinirole 37 symptom severity 37 Defined Benefit Pension Plan 37 Computed 37 nsec 37 0 document.write sline 37 #.#-# b [002] 37 tipranavir r 37 MSLT 37 neurologic progression 37 Nonstandard 37 Overnight Repurchase 37 tumor progression TTP 37 Selection Criteria 37 affective psychosis 37 + 37 Acclimation 37 adjunctive placebo 37 multiple linear regression 37 Yield Rises 37 ABILIFY Injection 37 #.#-# Contract Terms [002] 37 -Judge Kozinski 37 Active Ulcerative Colitis 37 H2RAs 37 Interest Rate 37 Obtains Financing 37 picometers 37 IMPORTANT OFFER INFORMATION 37 Strategic Asset Allocation 37 Measuring Device 37 Specifying 37 Actively Managed ETF 37 Pass Fail 37 Epithelial Cell 37 Thyroid Hormone 37 NB UVB 37 CorVue ™ 37 Commencement Date 37 Cu lb 37 Structural Changes 37 Bladder Cancer Risk 37 Highly Accurate 37 virologic response 37 Average Average 37 - -Ker WingHouse Bar 37 Specificity 37 + - Vulnerable 37 Million Cubic Feet 37 ADCS ADL 37 Legal #.# 37 #/#EV steps 37 Percent Reduction 37 hepatic enzymes 37 AIG Bailout 37 morphologic characteristics 37 Quarter Comparison 37 Emerging Mkts 37 HER2 expression 37 Lasting 37 Restrains 37 neurodevelopmental outcome 37 Municipal Funds Declare 37 Cardiorespiratory 37 Beta Blockers 37 Discounted Gift 37 Kinetex Announces 37 DCID 6 37 Colorimetric 37 Certain Cancers 37 Pos Driver 37 May Have Peaked 37 Input Voltage 37 Paliperidone 37 λ 37 strlen 37 Lung Cancer Risk 37 #/#/#-#/#/# [006] 37 virological response 37 Non Negotiable 37 Photoelectric Sensors 37 postop 37 virologic failure 37 Minimum Bid 37 sievert 37 Constrain 37 Stent Placement 37 Conductivity 37 Hysteresis 37 Practicable 37 Readmission 37 EUR#.# Billion [004] 37 Warrant Exercise Price 37 Being Studied 37 Exposure Compensation 37 Long Term 37 Correlated 37 Transferability 37 Dynamic Range 37 Fixed remuneration 37 commonly thrombocytopenia 37 MBS MORNING 37 #:# randomization 37 Funds Declare 37 non progressors 37 Obese Patients 37 acute febrile 37 timepoints 37 OGTT 37 -Wyndhams 37 Banker Acceptance 37 MTTF 37 Calculates 37 Outlooks #.#.# 37 postoperatively 37 vary depending 37 aortic crossclamp 37 CareerBuilder.com Survey Finds 37 USL# 37 Phase Shift Keying 37 Impair 37 innerHTML = 37 peri procedural 37 Muscle Wasting 37 #mg/dl 37 Periods 37 Posttraumatic Stress 37 ankle dorsiflexion 37 atheromatous 37 Reaches Highest 37 Stock Repurchases 37 BEXXAR Therapeutic Regimen 37 Interest Rate Derivatives 37 Default Risk 37 fluticasone salmeterol 37 What Constitutes 37 intraclass correlation coefficients 37 Jobless Claims Hit 37 linear interpolation 37 Index ETN NYSEArca 37 Barometric pressure 37 Required 37 Frequency Range 37 Intra Arterial 37 Zero Coupon 37 #.#:# #.#:# [001] 37 Marker Marker Marker Marker 37 partial thromboplastin 37 m/s2 37 QAB# indacaterol 37 Strike Length 37 aminotransferase elevations greater 37 Pressure Transducer 37 chronicity 37 Hepatitis C Treatment 37 tiotropium 37 Capitalisation 37 Dramatically Reduces 37 #mg/m# [002] 37 -RDPP 37 Multivariate 37 recurrent VTE 37 -Emily Kerstetter 37 Wtd 37 Electric Pressure Washers 37 inhaled iloprost 37 pharmacokinetics PK 37 benign gastric ulcers 37 requi . 37 term potentiation LTP 37 Breast Tumors 37 - -Hennebury 37 varies 37 Barely Changed 37 #mg/m# [001] 37 Major Depressive Disorder MDD 37 Therapy Improves 37 Airborne Geophysical 37 Tumor Marker 37 Achieve Optimal 37 IFRS IFRS 37 inhaled tobramycin 37 erosive esophagitis 37 See id 37 -Rejustors 37 DFARS #.#-# 37 Reevaluating 37 Northing Easting 37 Cluster headaches 37 Brightness Contrast 37 Reflectance 37 AVERAGE DAILY RESULTS 37 Sees Steady 37 DHCA 37 Deferrals 37 Probabilities 37 PHAZAR CORP Announces 37 Varies Widely 37 Short Term 37 Grading Scale 37 Blocked Arteries 36 By GlobalGrind Staff 36 Histogram 36 Rates Decline 36 Reprices 36 Reduce Expenses 36 Whitestone REIT Announces 36 neurocognitive function 36 Elasticity 36 Study Analyzes 36 SIMPADICO 36 User definable 36 MS DRG 36 XPEL Announces 36 Offer Amount 36 leucopenia 36 PSADT 36 psychodynamic psychotherapy 36 pharmacodynamic parameters 36 Quantifiable 36 -TUMS 36 mIU ml 36 Hedged 36 Banker Acceptances 36 Initialization 36 -Viejas Tribal Chairman 36 Rate Dips 36 El Niño Southern Oscillation 36 Permeation 36 adenoma recurrence 36 ASTM E# [002] 36 Excellon Announces 36 Treatment Reduces 36 Exchange Traded Notes 36 Cerebral Blood 36 Weighting 36 Yield Advantage 36 Complete Qualifying Transaction 36 covariate 36 Solar Radiation 36 Specifies 36 Coefficient 36 Rate Unchanged 36 DAS# scores 36 ipsilateral stroke 36 Incidence Rate 36 Module Enables 36 Funds Declare Monthly Dividends 36 Conversion Cycle 36 bipolar mania trials 36 Multiphase Flow 36 Infl 36 Mortgage Rates Continue 36 ≥ 36 cycle ergometer 36 Brain Aneurysms 36 LTC# utilizes 36 Amortized 36 Genetic Mutation 36 -Lighting Designers 36 randomisation 36 Tolerable 36 Exercise Type Expiry 36 calcium antagonist 36 Multivariable 36 Different Types Of 36 χ 36 telephoto focal 36 Calorie Intake 36 Finger Length 36 Voeckler clocked 36 mattcable# 36 Hedging Strategy 36 dose titration 36 Unsharp Mask 36 posttransplant 36 euthymic 36 symptom onset 36 Specially Designed 36 Full Width 36 -Genereaux 36 Surface Temperature 36 Spinal Fractures 36 electromyographic 36 Mortgage Rates Remain 36 CapLease Announces 36 Defined 36 #Vrms 36 Guaranteed 36 Proved Reserve 36 AMOR IPAT 36 Improves Accuracy 36 - Balance [005] 36 Criticality 36 Constant Currency 36 resolves spontaneously 36 Variable Rate 36 hPa 36 Term 36 p = NS 36 tumor histology 36 Magnification 36 Stress Levels 36 Could Save Lives 36 GAAP Adj 36 Fluctuation 36 Reported Outcome 36 #.# MHz [002] 36 salmeterol fluticasone 36 Astronauts Begin 36 Erase Gains 36 observable characteristics 36 Exercisable 36 6hr 36 HFRX 36 CCyR 36 Annualized Return